Quantbot Technologies’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.8K Sell
175
-384
-69% -$23.3K ﹤0.01% 1824
2026
Q1
$31K Buy
+559
New +$30.1K ﹤0.01% 1462
2023
Q3
Sell
-4,581
Closed -$93.2K 1517
2023
Q2
$93.2K Buy
4,581
+481
+12% +$9.75K 0.01% 1198
2023
Q1
$89.2K Buy
+4,100
New +$99.6K 0.01% 1122
2022
Q3
Sell
-1,700
Closed -$34K 1559
2022
Q2
$34K Buy
+1,700
New +$37.7K ﹤0.01% 1374
2022
Q1
Sell
-1,000
Closed -$34K 1614
2021
Q4
$34K Buy
1,000
+200
+25% +$6.34K ﹤0.01% 1123
2021
Q3
$21K Buy
+800
New +$20.3K ﹤0.01% 1256
2020
Q4
Sell
-2,129
Closed -$31K 1258
2020
Q3
$31K Buy
2,129
+1,609
+309% +$29K ﹤0.01% 937
2020
Q2
$11K Buy
+520
New +$9.51K ﹤0.01% 909
2020
Q1
Sell
-4,585
Closed -$74K 884
2019
Q4
$74K Buy
4,585
+4,085
+817% +$96.6K 0.01% 887
2019
Q3
$17K Sell
500
-1,200
-71% -$57.1K ﹤0.01% 1124
2019
Q2
$95K Buy
+1,700
New +$122K 0.01% 770
2018
Q4
Sell
-875
Closed -$87K 1010
2018
Q3
$87K Sell
875
-999
-53% -$82.9K 0.01% 916
2018
Q2
$133K Buy
1,874
+614
+49% +$51.5K 0.01% 821
2018
Q1
$131K Sell
1,260
-323
-20% -$36.4K 0.01% 784
2017
Q4
$159K Buy
+1,583
New +$117K 0.01% 751

Other funds holding ANAB

Quantbot Technologies's ANAB Position: Q2 2026 in Review

Quantbot Technologies reduced its AnaptysBio (ANAB) stake by 69% in Q2 2026, selling an estimated $23.3K and leaving 175 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1824.

Quantbot Technologies first reported a position in ANAB in Q4 2017 and has held it in 16 quarters since. The position peaked at $159K in Q4 2017. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Quantbot Technologies held 175 shares of AnaptysBio worth $11.8K as of Q2 2026.
  • Quantbot Technologies sold 384 AnaptysBio shares in Q2 2026, an estimated $23.3K.
  • AnaptysBio made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1824 holding.
  • Quantbot Technologies first reported a position in AnaptysBio in Q4 2017 and has held it in 16 quarters since.
  • Quantbot Technologies's AnaptysBio position peaked at $159K in Q4 2017.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.